Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 35 /hr
Hire Smadar K.
Australia
USD 35 /hr
Molecular biologist & cancer researcher with 10 years of training and expertise in translational cancer research.
Profile Summary
Subject Matter Expertise
Services
Writing
Technical Writing
Research
Market Research,
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis
Product Development
Product Validation
Work Experience
Senior Research Officer
Children's Cancer Research Unit, The Children's Hospital at Westmead
July 2021 - Present
Research Officer
Children's Cancer Research Unit
July 2017 - Present ![]()
Senior Research Assistant
Sheba Medical Center
January 2012 - August 2016 ![]()
Education
PhD in Biology (Biology)
Technion Israel Institute of Technology Faculty of Biology
October 2005 - July 2011 ![]()
BA in Molecular Biochemistry (Chemistry)
Technion Israel Institute of Technology
October 2002 - October 2005 ![]()
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Smadar Kahana-Edwin, Lucy E. Cain, Geoffrey McCowage, Artur Darmanian, Dale Wright, Anna Mullins, Federica Saletta, Jonathan Karpelowsky (2021). Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA Profiling . Cancers.
Smadar Kahana-Edwin, Lucy E. Cain, Geoffrey McCowage, Artur Darmanian, Dale Wright, Anna Mullins, Federica Saletta, Jonathan Karpelowsky (2021). Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and <i>ALK</i> Genotyping via Cell-Free Circulating Tumor DNA Profiling . Cancers.
Smadar Kahana‐Edwin, Geoffrey McCowage, Lucy Cain, Federica Saletta, Aysen Yuksel, Nicole Graf, Jonathan Karpelowsky(2020). Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma . Pediatric Blood & Cancer. 67. (11). Wiley
(2020). Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma . Pediatric Blood & Cancer.
(2020). TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients . Cancer Immunology, Immunotherapy.
(2020). ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast Cancer Research.
Dadiani M, Bossel Ben-Moshe N, Paluch-Shimon S, Perry G, Balint N, Marin I, Pavlovski A, Morzaev D, Kahana-Edwin S, Yosepovich A, et al.(2016). Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer . Clinical cancer research : an official journal of the American Association for Cancer Research.
Kahana-Edwin S, Stark M, Kassir Y(2013). Multiple MAPK cascades regulate the transcription of IME1, the master transcriptional activator of meiosis in Saccharomyces cerevisiae . PloS one.
Kahana S, Pnueli L, Kainth P, Sassi HE, Andrews B, Kassir Y(2010). Functional dissection of IME1 transcription using quantitative promoter-reporter screening . Genetics.